Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: acuransx_2000 who wrote (5857)	3/10/2002 10:03:27 PM
From: Jibacoa	Read Replies (1) of 52153

<< Anybody here following IBPI.>> Yes, I usually follow any stock that goes up 46.76% in one day, especially when it had given a "buy signal" in November.<g> The reason for the run-up according to an article on the current issue of Business Week is that some of the "insiders" (hedge funds from Soros and others <g>) have recently substantially increased their position, and (This according to Yahoo),the CFO also bought 25,000 shares in December IBPI has a trial going on for Iseganan HCl, an antibiotic to prevent oral mucositis, which is not an infrequent side effect of Ca chemotherapy. It also has a Phase III trial going for patients having radiation treatments for neck and head cancer. The CFO says the results are important for filing for fast approval with the FDA. An analyst from Lehman Brothers rates the stock a buy, with a 12-month target of 12. I will ask for Peter's indulgence this time, and post the links to some of IBPI's charts. (Those with an aversion to TA, please don't look at them). siliconinvestor.com siliconinvestor.com siliconinvestor.com Caveat: I am long IBPI.<g> Good luck to all. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next